Search

everythinglearnresearchcommunity

for

Search:↓

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Hair follicle culture helps develop new treatments for hair loss.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Hair loss from genetics and hormones can be treated with drugs or surgery.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Dermal papilla cells are key for hair growth and could help us understand and treat hair loss.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Laser-assisted drug delivery improves hair loss.

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Understanding hair biology is key to developing better treatments for hair and scalp issues.

PRP is effective for hair loss and might work better with other treatments, but more research is needed.

Combination therapies work better than single treatments for hair loss.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Androgens can both increase body hair and cause scalp hair loss.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.